Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001663577-24-000119
Filing Date
2024-04-16
Accepted
2024-04-16 15:55:21
Documents
53
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 skvi10k_123123.htm   iXBRL 10-K 731272
2 GRAPHIC image_001.jpg GRAPHIC 8188
3 GRAPHIC image_002.jpg GRAPHIC 11785
4 GRAPHIC image_003.jpg GRAPHIC 3068
5 GRAPHIC image_004.jpg GRAPHIC 3972
11 ex31_1.htm EX-31.1 8980
12 ex31_2.htm EX-31.2 8977
13 ex32_1.htm EX-32.1 3926
  Complete submission text file 0001663577-24-000119.txt   2943766

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE skvi-20231231.xsd EX-101.SCH 21903
7 XBRL CALCULATION FILE skvi-20231231_cal.xml EX-101.CAL 34832
8 XBRL DEFINITION FILE skvi-20231231_def.xml EX-101.DEF 52737
9 XBRL LABEL FILE skvi-20231231_lab.xml EX-101.LAB 165913
10 XBRL PRESENTATION FILE skvi-20231231_pre.xml EX-101.PRE 138979
57 EXTRACTED XBRL INSTANCE DOCUMENT skvi10k_123123_htm.xml XML 248911
Mailing Address 6320 S SANDHILL ROAD UNIT 9 LAS VEGAS NV 89120
Business Address 6320 S SANDHILL ROAD UNIT 9 LAS VEGAS NV 89120 702-433-7154
SKINVISIBLE, INC. (Filer) CIK: 0001085277 (see all company filings)

EIN.: 880344219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-25911 | Film No.: 24847720
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)